P Emery Selected Research

Fatigue

1/2010	Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial.
11/2008	Reduction of fatigue in Sjögren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study.
6/2008	Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti-tumor necrosis factor therapy.
9/2007	Quality of life in patients with rheumatoid arthritis: does abatacept make a difference?
2/2007	Abatacept improves both the physical and mental health of patients with rheumatoid arthritis who have inadequate response to methotrexate treatment.
12/2004	Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

P Emery Research Topics

Disease

84	Rheumatoid Arthritis 09/2020 - 02/2000
26	Necrosis 09/2020 - 07/2000
16	Arthritis (Polyarthritis) 10/2016 - 01/2000
14	Synovitis 12/2017 - 01/2000
13	Inflammation (Inflammations) 12/2023 - 08/2000
11	Ankylosing Spondylitis 01/2014 - 09/2004
9	Autoimmune Diseases (Autoimmune Disease) 11/2018 - 10/2000
8	Pain (Aches) 01/2020 - 05/2003
7	Psoriatic Arthritis 03/2016 - 05/2003
7	Rheumatic Diseases (Rheumatism) 03/2016 - 12/2000
6	Infections 04/2011 - 10/2003
6	Spondylarthropathies 07/2010 - 09/2001
6	Fatigue 01/2010 - 12/2004
5	Disease Progression 09/2004 - 05/2000
4	Systemic Scleroderma (Systemic Sclerosis) 07/2010 - 06/2001
4	Back Pain (Backache) 07/2010 - 09/2004
4	Osteitis 03/2010 - 09/2004
3	Injection Site Reaction 01/2018 - 05/2004
3	Exanthema (Rash) 11/2008 - 06/2000
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2004 - 01/2001
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2016 - 01/2014
2	Crohn Disease (Crohn's Disease) 04/2015 - 01/2003
2	Hypersensitivity (Allergy) 07/2011 - 06/2000
2	Sacroiliitis 07/2010 - 11/2008
2	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2010 - 04/2008
2	Tuberculosis (Tuberculoses) 06/2010 - 03/2001
2	Knee Osteoarthritis 04/2010 - 11/2007
2	Headache (Headaches) 11/2008 - 06/2000
2	Acne Vulgaris 05/2007 - 02/2001
2	Hypertension (High Blood Pressure) 01/2001 - 08/2000
2	Alopecia (Baldness) 06/2000 - 06/2000
1	Sjogren's Syndrome (Sjogren Syndrome) 12/2023
1	Cutaneous Lupus Erythematosus 10/2019
1	Joint Diseases (Joint Disease) 01/2016
1	Vasculitis (Vasculitides) 09/2014
1	Axial Spondyloarthritis 01/2014
1	Communicable Diseases (Infectious Diseases) 03/2011

Drug/Important Bio-Agent (IBA)

24	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 06/2000
19	Antirheumatic Agents (DMARD)IBA 01/2020 - 01/2000
13	Rituximab (Mabthera)FDA Link 12/2023 - 12/2006
13	Infliximab (Remicade)FDA Link 01/2014 - 11/2000
10	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2009 - 11/2000
9	Etanercept (Enbrel)FDA Link 01/2018 - 09/2001
8	Tumor Necrosis Factor InhibitorsIBA 03/2016 - 08/2006
8	Leflunomide (Arava)FDA LinkGeneric 11/2007 - 05/2000
7	Monoclonal AntibodiesIBA 06/2010 - 11/2000
6	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2009 - 02/2000
5	Biomarkers (Surrogate Marker)IBA 12/2023 - 06/2001
5	ametantrone (HAQ)IBA 01/2020 - 06/2000
5	Abatacept (Orencia)FDA Link 09/2014 - 02/2007
4	tocilizumab (atlizumab)FDA Link 01/2020 - 09/2006
4	Proteins (Proteins, Gene)FDA Link 10/2016 - 03/2001
4	AntibodiesIBA 09/2015 - 04/2006
4	Rheumatoid FactorIBA 06/2014 - 08/2000
4	C-Reactive ProteinIBA 07/2010 - 08/2000
4	GadoliniumIBA 03/2009 - 05/2001
4	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 04/2006 - 09/2004
3	Adalimumab (Humira)FDA Link 01/2020 - 12/2003
3	Anti-Citrullinated Protein AntibodiesIBA 12/2017 - 04/2006
3	AutoantibodiesIBA 09/2014 - 10/2000
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2014 - 08/2000
3	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 07/2010 - 11/2008
3	cyclic citrullinated peptideIBA 03/2010 - 04/2006
3	CytokinesIBA 04/2008 - 06/2001
3	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 02/2008 - 09/2004
2	InterferonsIBA 11/2018 - 10/2018
2	ElementsIBA 12/2017 - 05/2009
2	Certolizumab Pegol FDA Link 01/2017 - 05/2015
2	Peptides (Polypeptides)IBA 09/2015 - 02/2011
2	Immunomodulating AgentsIBA 04/2015 - 04/2011
2	EpitopesIBA 06/2014 - 01/2009
2	SteroidsIBA 01/2014 - 11/2008
2	HLA-DRB1 Chains (HLA DRB1)IBA 02/2012 - 08/2000
2	VaccinesIBA 04/2011 - 03/2011
2	HLA-B27 Antigen (HLA B27 Antigen)IBA 11/2009 - 11/2008
2	TACI receptor-IgG Fc fragment fusion proteinIBA 07/2009 - 01/2008
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 11/2008 - 09/2006
2	Minocycline (Cyclops)FDA LinkGeneric 05/2007 - 02/2001
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2006 - 01/2001
2	Methylprednisolone FDA LinkGeneric 05/2004 - 05/2001
2	AntigensIBA 03/2001 - 02/2001
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 08/2000 - 06/2000
2	EnzymesIBA 06/2000 - 06/2000
1	Biosimilar PharmaceuticalsIBA 09/2020
1	tofacitinibIBA 01/2020
1	TESIBA 01/2020
1	baricitinibIBA 01/2020
1	Interferon Type IIBA 11/2018
1	etanercept biosimilar SB4IBA 01/2018
1	MicroRNAs (MicroRNA)IBA 12/2017
1	Adenosine Monophosphate (AMP)IBA 01/2016
1	Antimicrobial PeptidesIBA 01/2016
1	Amino Acids FDA Link 02/2012
1	Genetic Markers (Genetic Marker)IBA 12/2011

Therapy/Procedure

44	Therapeutics 12/2023 - 01/2000
6	Biological Therapy 08/2011 - 09/2003
5	Stem Cell Transplantation 08/2004 - 12/2000
2	Remission Induction 06/2014 - 01/2014
2	Drug Tapering 01/2001 - 08/2000
1	Lasers (Laser) 10/2019